WallStreetZenWallStreetZen

NASDAQ: PTIX
Protagenic Therapeutics Inc Stock

$1.77-0.07 (-3.8%)
Updated Sep 27, 2023
PTIX Price
$1.77
Fair Value Price
N/A
Market Cap
$7.67M
52 Week Low
$1.25
52 Week High
$2.74
P/E
-2.24x
P/B
1.42x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$3.45M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.28
Operating Cash Flow
-$3M
Beta
0.16
Next Earnings
Nov 14, 2023
Ex-Dividend
N/A
Next Dividend
N/A

PTIX Overview

Protagenic Therapeutics, Inc. is a biotechnology company developing naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. It uses a search algorithm to identify new bioactive peptides in the genome. The company's lead product candidate, PT00114, is targeted to inhibit anxiety and depression without interfering with normal brain function. Protagenic Therapeutics was founded in 2004 and is headquartered in New York, NY.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PTIX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PTIX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PTIX is good value based on its book value relative to its share price (1.42x), compared to the US Biotechnology industry average (5.12x)
P/B vs Industry Valuation
PTIX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more PTIX due diligence checks available for Premium users.

Be the first to know about important PTIX news, forecast changes, insider trades & much more!

PTIX News

Valuation

PTIX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.24x
Industry
13.5x
Market
13.45x

PTIX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.42x
Industry
5.12x
PTIX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PTIX's financial health

Profit margin

Revenue
$0.0
Net Income
-$1.2M
Profit Margin
0%
PTIX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$6.9M
Liabilities
$1.5M
Debt to equity
0.28
PTIX's short-term assets ($6.92M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PTIX's short-term assets ($6.92M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PTIX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PTIX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.5M
Investing
$1.6M
Financing
$0.0
PTIX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

PTIX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
PTIX$7.67M-3.80%-2.24x1.42x
BNTC$7.59M-5.40%-21.13x37.58x
PYPD$7.77M-10.38%-0.14x0.93x
LEXX$7.77M+1.05%-0.85x1.77x
CELZ$7.80M+1.68%-0.73x0.57x

Protagenic Therapeutics Stock FAQ

What is Protagenic Therapeutics's quote symbol?

(NASDAQ: PTIX) Protagenic Therapeutics trades on the NASDAQ under the ticker symbol PTIX. Protagenic Therapeutics stock quotes can also be displayed as NASDAQ: PTIX.

If you're new to stock investing, here's how to buy Protagenic Therapeutics stock.

What is the 52 week high and low for Protagenic Therapeutics (NASDAQ: PTIX)?

(NASDAQ: PTIX) Protagenic Therapeutics's 52-week high was $2.74, and its 52-week low was $1.25. It is currently -35.4% from its 52-week high and 41.71% from its 52-week low.

How much is Protagenic Therapeutics stock worth today?

(NASDAQ: PTIX) Protagenic Therapeutics currently has 4,330,959 outstanding shares. With Protagenic Therapeutics stock trading at $1.77 per share, the total value of Protagenic Therapeutics stock (market capitalization) is $7.67M.

Protagenic Therapeutics stock was originally listed at a price of $13,389,760.28 in Dec 31, 1997. If you had invested in Protagenic Therapeutics stock at $13,389,760.28, your return over the last 25 years would have been -100%, for an annualized return of -46.93% (not including any dividends or dividend reinvestments).

How much is Protagenic Therapeutics's stock price per share?

(NASDAQ: PTIX) Protagenic Therapeutics stock price per share is $1.77 today (as of Sep 27, 2023).

What is Protagenic Therapeutics's Market Cap?

(NASDAQ: PTIX) Protagenic Therapeutics's market cap is $7.67M, as of Sep 28, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Protagenic Therapeutics's market cap is calculated by multiplying PTIX's current stock price of $1.77 by PTIX's total outstanding shares of 4,330,959.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.